Item | (Normal range) | Nov 2009 on attack | Nov 2012 on admission | Item | (Normal range) | Nov 2009 on attack | Nov 2012 on admission | |||
Total protein | (g/dL) | (6.7 - 8.2) | 7.0 | 8.3 | Anti-mitochondrial Ab | (Negative) | Negative | |||
Albumin | (g/dL) | (3.8 - 5.2) | 4.0 | Anti-smooth muscle Ab | (Negative) | Negative | ||||
α2 globulin | (%) | (4.8 - 8.6) | 8.6 | Anti-nuclear Ab | <40× | 160× | 80× | |||
Total bilirubin | (mg/dL) | (0.2 - 1.2) | 0.8 | 0.6 | Homogeneous & speckled | |||||
Alkaline phosphatase | (IU/L) | (101 - 340) | 478 | 758 | Rheumatoid factor | 0-10 | 0 | |||
AST | (IU/L) | (7 - 30) | 360 | 34 | P-ANCA | <3.5 | 21 | |||
ALT | (IU/L) | (0 - 32) | 174 | 23 | Anti-ribonucler protein Ab | (Negative) | Negative | |||
Lactate dehydrogenase | (IU/L) | (101 - 230) | 328 | 221 | IgG | (mg/dL) | (700 - 2000) | 1653 | 2271 | |
Total cholesterol | (mg/dL) | (110 - 220) | 122 | 104 | IgG4 | (mg/dL) | (4.8 - 105.0) | 10.5 | ||
Blood urea nitrogen | (mg/dL) | (7 - 20) | 9.6 | 4.7 | IgA | (mg/dL) | (94 - 365) | 124 | 141 | |
Creatinine | (mg/dL) | (0.4 - 1.1) | 0.5 | 0.5 | IgM | (mg/dL) | (30 - 120) | 84 | 93 | |
C-reactive protein | (mg/dL) | (≤0.3) | 0.4 | 1.3 | IgE | (IU/mL) | (<173) | 533 | ||
ESR | (mm/hr) | (<15) | 68 | Stool culture | Negative | Negative | ||||
Blood sugar | (mg/dL) | (60 - 120) | 113 | 106 | CMV antigenemia | 0 | 0 | |||
Hemoglobin | (mg/dL) | (12.0 - 15.1) | 13.1 | 12.1 | Anti-CMV Ab IgM | <0.80 | 0.31 | 0.58 | ||
White blood cell | (/mm3) | (3900 - 8800) | 15,300 | 6200 | Anti-CMV Ab IgG | <2.0 | 2.0 | <2.0 | ||
Platelet | (×104/mm3) | (15.2 - 31.4) | 21.7 | 38.4 | EBV VCA IgG | <10 | 640 | |||
Hepatitis B surface Ag | Negative | Negative | EBV VCA IgM | <10 | <10 | |||||
Hepatitis C virus Ab | Negative | Negative | EBNA | <10 | <10 | |||||
IgM Hepatitis A Ab | Negative | Negative | HLA-DR | DR 15 | ||||||